Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 4/20 | 0.62 |
| ▸ | APP | P05067 | 3/20 | 0.60 |
| ▸ | MIF | P14174 | 1/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | SNCA | P37840 | 2/20 | 0.47 |
| ▸ | CD38 | P28907 | 1/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25421370 | 0.86 | ALOX5 (0.62) | ALOX5APPMIFXDHMAPT | |
| SCHEMBL278379 | 0.82 | ALOX5 (0.73) | ALOX5ESR2ESR1HSD17B1HSD17B2 | |
| SCHEMBL33527 | 0.82 | — | — | |
| SCHEMBL4862349 | 0.82 | ALOX5 (0.60) | ALOX5APPMIF | |
| SCHEMBL29829218 | 0.82 | — | — | |
| SCHEMBL10097918 | 0.80 | ESR2 (0.53) | ALOX5MAPTESR2ESR1HSD17B1 | |
| SCHEMBL3811869 | 0.80 | ALOX5 (0.70) | ALOX5ESR2ESR1HSD17B1HSD17B2 | |
| SCHEMBL31419103 | 0.79 | ESR2 (0.74) | ALOX5ESR2ESR1HSD17B1HSD17B2 | |
| SCHEMBL28819464 | 0.79 | ESR2 (0.74) | ALOX5ESR2ESR1HSD17B1HSD17B2 | |
| SCHEMBL29666588 | 0.79 | ESR2 (0.74) | ALOX5ESR2ESR1HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115266282-A | Pathological image automatic identification method based on combination of three methods of HE staining, ki67 and P16 | 武汉兰丁云医学检验实验室有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-116998459-A | Immunodeficient mice expressing human interleukin 15 | 杰克逊实验室 | 2023-11-07 | — | — | CN | disclosed |
| US-20230201226-A1 | COMBINATION THERAPY FOR REDUCING DRUG-INDUCED NEPHROTOXICITY, DYSLIPIDEMIA AND HYPERGLYCEMIA | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-06-29 | — | — | US | disclosed |
| CN-115266282-A | Pathological image automatic identification method based on combination of three methods of HE staining, ki67 and P16 | 武汉兰丁云医学检验实验室有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-113180007-B | Exudative animal pneumonia model construction method | 扬州大学 | 2022-08-19 | — | — | CN | disclosed |
| CN-114671844-A | Method for separating and preparing 4-O-methyl hematoxylin | 浙江工业大学 | 2022-06-28 | — | — | CN | disclosed |
| CN-102861338-A | Combinations of comprising a bcr-abl, c-kit and pdgf-r tyrosine kinase inhibitor used for treating cancer | NOVARTIS AG | 2013-01-09 | — | — | CN | disclosed |
| EP-1064313-A4 | SELECTED HIGH THERMAL NOVOLAKS AND POSITIVE-WORKING RADIATION-SENSITIVE COMPOSITIONS | ARCH SPEC CHEM INC (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-1064313-A1 | SELECTED HIGH THERMAL NOVOLAKS AND POSITIVE-WORKING RADIATION-SENSITIVE COMPOSITIONS | ARCH SPECIALTY CHEMICALS, INC. (US) | 2001-01-03 | — | — | EP | disclosed |
| US-5985507-A | PHOTORESISTS WITH THERMAL PROPERTIES | OLIN MICROELECTRONIC CHEMICALS, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999042507-A1 | SELECTED HIGH THERMAL NOVOLAKS AND POSITIVE-WORKING RADIATION-SENSITIVE COMPOSITIONS | OLIN MICROELECTRONIC CHEMICALS, INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| US-5674657-A | PHENOLIC RESIN COPOLYMER COMPRISING META-CRESOL, PARA-CRESOL AND OTHER PHENOLIC MONOMER SELECTED FROM XYLENOLS, METHOXYPHENOLS; RADIATION SENSITIVITY | OLIN MICROELECTRONIC CHEMICALS, INC. (US) | 1997-10-07 | — | — | US | disclosed |